씨젠

096530KOSDAQ

67.8 / 100

Reference Date: 2026-09-08

Financial Score19.5 / 40

News Sentiment21.3 / 25

Momentum13.0 / 20

Disclosure14.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Rose 8.7% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Seegene is a molecular diagnostics specialist established in 2000, leveraging DNA/RNA analysis to detect disease causes, with 91% of its revenue from exports globally. The company utilizes its proprietary Syndromic qPCR technology and 19 patents to develop multiplex diagnostic products, and is expanding AI-driven diagnostic reagent development through collaborations with Microsoft and Springer Nature.

Number of Employees

822people

Average Salary

95.0M KRW

Score Calculation Basis

Detailed Financial Score

PER

33.85Industry Average 15.000.0Point

2.3x industry avg (risky)

PBR

1.61Industry Average 1.202.5Point

Higher than industry avg (caution)

ROE

4.82Industry Average 8.002.5Point

Below industry avg

Debt Ratio

4.85Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20256.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲13.6% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲177.4% (2-year basis)

ROE Trend

1.0 / 4

Avg ROE 1.0% (improving, 3yr)

Detailed News Sentiment

6 totalPositive 6Neutral 0Negative 0Average Sentiment Score 85

Positive
씨젠의 반전…독 됐던 해외법인 살아났다
씨젠의 해외법인 수익성 개선으로 실적 회복이 가속화되고 있다.
Positive
[특징주] 코로나19 감염 증가 소식에 관련주 급등(종합)
코로나19 감염 증가 소식으로 씨젠을 포함한 관련 테마주가 급등했다.
Positive
[특징주] 코로나19 재확산 소식에… 제약·바이오株, 일제히 강세
코로나19 재확산 소식으로 제약 및 바이오 관련 주식들이 강세를 보임.

Detailed Momentum

52-week position6.0Point

52w upper range (69%)

Current 31,400Won52-week high 35,65052-week low 21,850

1-month return5.0Point

1m +8.65% (rising)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

7 totalPositive 2Neutral 5Negative 0

Neutral주식등의대량보유상황보고서(일반)2026-08-26
Neutral자기주식처분결과보고서2026-08-21
Neutral반기보고서 (2026.06)2026-08-14
Neutral주식소각결정2026-08-12
Positive중간(분기)배당을위한주주명부폐쇄(기준일)결정2026-08-12